Drug
Lenograstim clinical trials
How studies write it
Studies that test it under each name
Name
Studies by the year they started
6 studies that test it; most in 2003 (1)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 4
Ludwig-Maximilians - University of Munich (1) · Sanofi (1) · WiSP Wissenschaftlicher Service Pharma GmbH (1) · CellProthera (1) · DERSHENG SUN (1) · University of Pisa (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Lenograstim is read from its arms, and is right about nine times in ten.
Testing it · 6
- Donation of Whole Blood by Healthy Volunteers After Mobilisation by Haematopoietic Growth Factor (Rhu-G-CSF = Granocyte)TerminatedPhase 1CellProtheraNCT05594433Written as Lenograstim
- Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial InfarctionCompletedPhase 2/3Ludwig-Maximilians - University of MunichNCT00650143Written as Lenograstim (GRANOCYTE)=GCSF
- Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)Status unknownNot applicableDERSHENG SUNNCT03498248Written as lenograstim
- A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based RegimenCompletedPhase 4SanofiNCT01107756Written as LENOGRASTIM (GRANOGYTE 34)
- Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose TherapyCompletedPhase 2/3WiSP Wissenschaftlicher Service Pharma GmbHNCT01085058Written as lenograstim
- Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple MyelomaStatus unknownPhase 3University of PisaNCT00932217Written as lenograstim
Given in every arm · 8 — Lenograstim is usual care beside what is tested
- A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)TerminatedPhase 2/3Barts & The London NHS TrustNCT01907009Written as Lenograstim
- Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With AzacitidineCompletedPhase 2University of UlmNCT01180322Written as Lenograstim
- Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast CancerCompletedPhase 3Hellenic Oncology Research GroupNCT00615602Written as Granulocyte-colony stimulating growth factor
- Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast CancerCompletedPhase 3Hellenic Oncology Research GroupNCT01985724Written as Granulocyte-colony stimulating growth factor
- Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCLCompletedPhase 1/2Asan Medical CenterNCT00379574Written as Lenograstim
- Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell TumorsStatus unknownPhase 1/2University of SouthamptonNCT00551122Written as lenograstim
- Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell LymphomaStatus unknownPhase 3Fondazione Italiana Linfomi - ETSNCT00499018Written as Lenograstim
- Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast CancerCompletedPhase 3Hellenic Oncology Research GroupNCT00431080Written as Granulocyte-colony stimulating growth factor
As the comparator · 1 — what is tested is compared with Lenograstim
Codes
What other systems call Lenograstim · ClinicalTrials.gg INT006822
- MeSH (NLM) D000078224LenograstimConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6WS4C399GBLENOGRASTIMConfirmed FDA, NLM, Wikidata
- RxNorm 70167Confirmed FDA, Wikidata
- Wikidata Q6523037lenograstimConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C49234LenograstimOne source FDA
- DrugBank DB13144One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078224 | Lenograstim | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6WS4C399GB | LENOGRASTIM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 70167 | — | Confirmed FDA, Wikidata |
| Wikidata | Q6523037 | lenograstim | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C49234 | Lenograstim | One source FDA |
| DrugBank | DB13144 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.